Stephen Squin­to talks writ­ing checks and next-gen obe­si­ty drugs as JP Mor­gan clos­es first $500M+ biotech fund

11 months ago
People
Financing

Roche de­tails Columvi OS da­ta in quest for ex­pand­ed lym­phoma ap­proval

11 months ago
R&D

In­novent de­tails Phase 3 weight loss da­ta from Lil­ly-part­nered GLP-1 in Chi­nese pa­tients

11 months ago
R&D

Bill Haney gives up CEO post at Sky­hawk, be­comes chair­man; Bay­er parts ways with head of biotech

11 months ago
People
Peer Review

AI drug dis­cov­ery start­up goes pub­lic in Hong Kong, nab­bing $115M to build on phar­ma part­ner­ships

11 months ago
Financing
China

Up­dat­ed: Telix Phar­ma­ceu­ti­cals pulls Nas­daq list­ing plans just be­fore trad­ing was to start

11 months ago
Financing

Bris­tol My­er­s' can­cer drug Aug­ty­ro wins new ac­cel­er­at­ed ap­proval in sol­id tu­mors

11 months ago
Pharma
FDA+

Stake­hold­ers weigh in on po­ten­tial re­forms to FDA ad­vi­so­ry com­mit­tee process

11 months ago
Pharma
FDA+

Phar­ma in­dus­try prais­es Supreme Court's re­jec­tion of abor­tion pill chal­lenge

11 months ago
Pharma
FDA+

Tele­health start­up Done's ex­ecs ar­rest­ed and charged for al­leged Adder­all scheme, DOJ says

11 months ago
Startups
Pharma

Alchem faces fines over price-fix­ing al­le­ga­tion from the Eu­ro­pean Com­mis­sion

11 months ago
Pharma
Manufacturing

Ra­dio­phar­ma ex­ecs warn that lutetium could be at risk of short­age 

11 months ago
Manufacturing

Siegfried nabs US site from Cu­ria; Mer­ck KGaA pumps €62M more in­to its head­quar­ters

11 months ago
Manufacturing

Ul­tragenyx to seek ac­cel­er­at­ed ap­proval for rare dis­ease gene ther­a­py

11 months ago
Cell/Gene Tx
FDA+

Uro­Gen touts long du­ra­tion of re­sponse for its blad­der can­cer chemother­a­py gel

11 months ago
R&D

J&J re­turns bis­pe­cif­ic T cell en­gager to Xen­cor, re­duc­ing scope of part­ner­ship

11 months ago
Deals
R&D

Avid­i­ty’s $300M of­fer­ing; Rap­port rais­es $174M

11 months ago
News Briefing

Is $13B De­vot­ed Health suc­ceed­ing where oth­er in­sur­ance up­starts have failed?

11 months ago
Startups
Health Tech

Ab­b­Vie banks on sec­ond-gen TL1A pro­gram, li­cens­ing an­ti­body from Fu­ture­Gen

11 months ago
Deals

'Speed is every­thing': Ver­sant-backed im­munol­o­gy start­up rais­es $125M with plans for quick da­ta

11 months ago
Financing
Startups

Sur­prise flop for Cara’s oral pru­ri­tus drug forces com­pa­ny to cut its last R&D pro­gram

11 months ago
R&D

Barinthus Bio to lay off 25% of its work­force and fo­cus on just two pro­grams

11 months ago
People
R&D

Ex­clu­sive: For­mer Mer­ck sci­en­tists raise $85M to map and drug pro­tein in­ter­ac­tions in can­cer and au­toim­mune dis­ease

11 months ago
Financing
Startups

On­ly a third of em­ploy­ers and health plans cov­er GLP-1 drugs for weight loss, re­port says

11 months ago
Pharma
Health Tech
First page Previous page 135136137138139140141 Next page Last page
A service from the Financial Times